ga naar hoofdinhoud
Informatie voor zorgverleners Behandelprotocollen Myelodysplastisch syndroom (MDS) Richtlijnen en literatuur

Richtlijnen

Klik HIER voor de richtlijn 'Myelodysplastisch syndroom' van het European LeukemiaNet.

Klik HIER voor de richtlijn 'Myelodysplastisch syndroom' van het EU-MDS consortium.

Literatuur

  1. Döhner H. et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN - Blood 2022 - 140 (12): 1345-1377
  2. Arber D.A. et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical and genomic data - Arber et al. - Blood 2022 - 140 (11): 1200-1228
  3. Khoury et al. The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic dendritic neoplasms - Leukemia 2022 - 36: 1703-1719
  4. Greenberg  PL et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood 2012; 120: 2454-2465
  5. Greenberg PL et al. International prognostic scoring system for myelodysplastic syndromes. Blood 1997; 89: 2079-2088
  6. Malcovati L et al. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. Blood 2013 122:2943-2964
  7. Cheson B.D. et al. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood 2006, volume 108, number 2
  8. Bernard E. et al. Molecular international prognostic scoring system for myelodysplastic syndromes. NEJM Evid 2022;1(7)

 

Ga terug naar de MDS homepage of lees meer over MDS:

Ga terug naar de algemene homepage Behandelprotocollen.